id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-009278-98ebmd33	Ferreira-Coimbra, João	Burden of Community-Acquired Pneumonia and Unmet Clinical Needs	2020-02-18		.txt	text/plain	5567	282	39	Community-acquired pneumonia (CAP) is the leading cause of death among infectious diseases and an important health problem, having considerable implications for healthcare systems worldwide. Recently, Nature Medicine published the first use of phages to treat a multidrug-resistant (MDR) microorganism [3] and Lancet Infectious Diseases reported the first use of pneumolysin in severe CAP treatment added to standard of care in a phase II trial [4] . Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study Incidence rate of community-acquired pneumonia in adults: a population-based prospective active surveillance study in three cities in South America Disease burden and etiologic distribution of community-acquired pneumonia in adults: evolving epidemiology in the era of pneumococcal conjugate vaccines Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial	./cache/cord-009278-98ebmd33.txt	./txt/cord-009278-98ebmd33.txt